2018 annual financial data
Aquestive Therapeutics 2018 Operating margin
Direct answer
Operating margin was -72.57%.
Operating income was -48,934,000 USD and net income was -61,376,000 USD.
Operating cash flow was -12,991,000 USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 67,430,000 USD
- Operating income
- -48,934,000 USD
- Net income
- -61,376,000 USD
- Operating cash flow
- -12,991,000 USD